OPKO Health Future Growth

Future criteria checks 0/6

OPKO Health is forecast to grow earnings and revenue by 46.1% and 6.1% per annum respectively while EPS is expected to grow by 45.2% per annum.

Key information

46.1%

Earnings growth rate

45.2%

EPS growth rate

Healthcare earnings growth12.3%
Revenue growth rate6.1%
Future return on equityn/a
Analyst coverage

Good

Last updated03 Mar 2024

Recent future growth updates

Recent updates

OPKO Health, Inc. (NASDAQ:OPK) Not Flying Under The Radar

Dec 30
OPKO Health, Inc. (NASDAQ:OPK) Not Flying Under The Radar

Is OPKO Health (NASDAQ:OPK) A Risky Investment?

Oct 03
Is OPKO Health (NASDAQ:OPK) A Risky Investment?

OPKO Health, Inc.'s (NASDAQ:OPK) 28% Share Price Surge Not Quite Adding Up

Jul 24
OPKO Health, Inc.'s (NASDAQ:OPK) 28% Share Price Surge Not Quite Adding Up

Would OPKO Health (NASDAQ:OPK) Be Better Off With Less Debt?

Jun 07
Would OPKO Health (NASDAQ:OPK) Be Better Off With Less Debt?

Is OPKO Health (NASDAQ:OPK) Using Too Much Debt?

Jan 04
Is OPKO Health (NASDAQ:OPK) Using Too Much Debt?

OPKO Health: Assessing If Significant Potential Can Be Realized

Sep 15

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

Sep 05
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

OPKO Health: 14%+ Short Interest Means More Volatility Over The Near Term

Jun 21

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

Apr 29
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

OPKO Health: A Great Long-Term Investment In Health

Apr 05

OPKO Health Is Risky But Might Make You Money

Mar 29

Analysts Have Just Cut Their OPKO Health, Inc. (NASDAQ:OPK) Revenue Estimates By 14%

Feb 27
Analysts Have Just Cut Their OPKO Health, Inc. (NASDAQ:OPK) Revenue Estimates By 14%

OPKO Health (NASDAQ:OPK) Has A Pretty Healthy Balance Sheet

Jan 12
OPKO Health (NASDAQ:OPK) Has A Pretty Healthy Balance Sheet

OPKO Health: Undervalued Opportunity

Dec 23

OPKO Health: Bullish Case Still Intact

Dec 15

We Think OPKO Health (NASDAQ:OPK) Can Stay On Top Of Its Debt

Sep 27
We Think OPKO Health (NASDAQ:OPK) Can Stay On Top Of Its Debt

OPKO Health: A Defensive, Long-Term Holding

Sep 19

Earnings and Revenue Growth Forecasts

NasdaqGS:OPK - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026925-34-2N/A2
12/31/2025847-187-40-1435
12/31/2024772-262-108-1876
12/31/2023863-189-44-28N/A
9/30/2023867-208-41-22N/A
6/30/2023868-209-110-87N/A
3/31/2023913-291-120-98N/A
12/31/20221,004-328-120-95N/A
9/30/20221,220-317-94-69N/A
6/30/20221,426-202-28-4N/A
3/31/20221,559-117-36-8N/A
12/31/20211,775-30638N/A
9/30/20211,868764678N/A
6/30/20211,9107173108N/A
3/31/20211,76912172109N/A
12/31/20201,43531639N/A
9/30/20201,165-114-72-41N/A
6/30/2020966-200-151-128N/A
3/31/2020891-293-182-167N/A
12/31/2019902-315-185-173N/A
9/30/2019899-279-173-161N/A
6/30/2019920-244-181-159N/A
3/31/2019958-191-147-123N/A
12/31/2018990-153-137-109N/A
9/30/2018929-295-112-72N/A
6/30/2018926-303-131-88N/A
3/31/2018955-314-137-94N/A
12/31/2017966-305-139-92N/A
9/30/20171,081-101N/A-64N/A
6/30/20171,133-80N/A-58N/A
3/31/20171,197-48N/A7N/A
12/31/20161,117-48N/A32N/A
9/30/20161,222-10N/A-8N/A
6/30/20161,067133N/A-7N/A
3/31/201675375N/A-84N/A
12/31/2015492-30N/A164N/A
9/30/2015241-85N/A149N/A
6/30/2015118-262N/A159N/A
3/31/201599-244N/A171N/A
12/31/201491-172N/A-90N/A
9/30/201486-135N/A-92N/A
6/30/201487-147N/A-82N/A
3/31/201487-125N/A-64N/A
12/31/201397-115N/A-56N/A
9/30/201392-99N/A-35N/A
6/30/201383-49N/A-26N/A
3/31/201370-57N/A-29N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OPK is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OPK is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OPK is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OPK's revenue (6.1% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: OPK's revenue (6.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OPK's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.